NEW Australian research published in the MJA has revealed high risk rural patients are not receiving anticoagulant therapy when most should be taking non-vitamin K oral anticoagulant (NOAC) therapy, which has been shown to be safer than warfarin.
"Improving anticoagulation therapy rates for people with AF [atrial fibrillation] provides the greatest opportunity for reducing the incidence of ischaemic stroke in rural Australia," authors wrote.
Visit mja.com.au to access the study abstract.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jan 18
